Molecular Pharmacology: 46 (5)

November 01, 1994; Volume 46,Issue 5

You have access
Nucleotide-independent modulation of Ca(2+)-dependent K+ channel current by a mu-type opioid receptor.
W A Twitchell and S G Rane

Molecular Pharmacology November 1994, 46 (5) 793-798;
You have access
Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands.
E L Barker, H L Kimmel and R D Blakely

Molecular Pharmacology November 1994, 46 (5) 799-807;
You have access
Functional reconstitution of platelet thromboxane A2 receptors with Gq and Gi2 in phospholipid vesicles.
F Ushikubi, K Nakamura and S Narumiya

Molecular Pharmacology November 1994, 46 (5) 808-816;
You have access
Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes.
H Nonaka, A Mori, M Ichimura, T Shindou, K Yanagawa, J Shimada and H Kase

Molecular Pharmacology November 1994, 46 (5) 817-822;
You have access
Cloning, expression, and tissue distribution of the rat homolog of the bovine alpha 1C-adrenergic receptor provide evidence for its classification as the alpha 1A subtype.
D M Perez, M T Piascik, N Malik, R Gaivin and R M Graham

Molecular Pharmacology November 1994, 46 (5) 823-831;
You have access
Coupling of the C5a receptor to Gi in U-937 cells and in cells transfected with C5a receptor cDNA.
M Vanek, L D Hawkins and F Gusovsky

Molecular Pharmacology November 1994, 46 (5) 832-839;
You have access
Bryostatin 1 protects protein kinase C-delta from down-regulation in mouse keratinocytes in parallel with its inhibition of phorbol ester-induced differentiation.
Z Szallasi, M F Denning, C B Smith, A A Dlugosz, S H Yuspa, G R Pettit and P M Blumberg

Molecular Pharmacology November 1994, 46 (5) 840-850;
You have access
Potentiation of gamma-aminobutyric acid type A receptor-mediated chloride currents by novel halogenated compounds correlates with their abilities to induce general anesthesia.
S J Mihic, S J McQuilkin, E I Eger, P Ionescu and R A Harris

Molecular Pharmacology November 1994, 46 (5) 851-857;
You have access
Site-directed mutagenesis of N-linked glycosylation sites on the gamma-aminobutyric acid type A receptor alpha 1 subunit.
A L Buller, G A Hastings, E F Kirkness and C M Fraser

Molecular Pharmacology November 1994, 46 (5) 858-865;
You have access
Interaction of an estramustine photoaffinity analogue with cytoskeletal proteins in prostate carcinoma cells.
L A Speicher, N Laing, L R Barone, J D Robbins, K B Seamon and K D Tew

Molecular Pharmacology November 1994, 46 (5) 866-872;
You have access
Ethanol-responsive genes in neural cells include the 78-kilodalton glucose-regulated protein (GRP78) and 94-kilodalton glucose-regulated protein (GRP94) molecular chaperones.
M F Miles, N Wilke, M Elliot, W Tanner and S Shah

Molecular Pharmacology November 1994, 46 (5) 873-879;
You have access
Transcriptional regulation of secretogranin II and chromogranin B by cyclic AMP in a rat pheochromocytoma cell line.
M E Thompson, D L Valentine, S J Strada, J A Wagner and J G Scammell

Molecular Pharmacology November 1994, 46 (5) 880-889;
You have access
Programmed cell death (apoptosis) of mouse fibroblasts is induced by the topoisomerase II inhibitor etoposide.
K Mizumoto, R J Rothman and J L Farber

Molecular Pharmacology November 1994, 46 (5) 890-895;
You have access
The daunorubicin-binding protein of Mr 54,000 is an aldehyde dehydrogenase and is down-regulated in mouse liver tumors and in tumor cell lines.
P Banfi, C Lanzi, F S Falvella, M Gariboldi, R A Gambetta and T A Dragani

Molecular Pharmacology November 1994, 46 (5) 896-900;
You have access
Doxorubicin-induced DNA degradation in murine thymocytes.
G Zaleskis, E Berleth, S Verstovsek, M J Ehrke and E Mihich

Molecular Pharmacology November 1994, 46 (5) 901-908;
You have access
Transcriptional up-regulation of gamma-glutamylcysteine synthetase gene expression in melphalan-resistant human prostate carcinoma cells.
R T Mulcahy, S Untawale and J J Gipp

Molecular Pharmacology November 1994, 46 (5) 909-914;
You have access
Analysis of the four alleles of the murine aryl hydrocarbon receptor.
A Poland, D Palen and E Glover

Molecular Pharmacology November 1994, 46 (5) 915-921;
You have access
Functional cytochrome P4503A isoforms in human embryonic tissues: expression during organogenesis.
H Y Yang, Q P Lee, A E Rettie and M R Juchau

Molecular Pharmacology November 1994, 46 (5) 922-928;
You have access
Selectivity of agonists for cloned alpha 1-adrenergic receptor subtypes.
K P Minneman, T L Theroux, S Hollinger, C Han and T A Esbenshade

Molecular Pharmacology November 1994, 46 (5) 929-936;
You have access
Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonists and inverse agonists.
R S Westphal and E Sanders-Bush

Molecular Pharmacology November 1994, 46 (5) 937-942;
You have access
Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo.
S Patel, A J Smith, K L Chapman, A E Fletcher, J A Kemp, G R Marshall, R J Hargreaves, W Ryecroft, L L Iversen and S D Iversen

Molecular Pharmacology November 1994, 46 (5) 943-948;
You have access
Discrimination between putative bradykinin B2 receptor subtypes in guinea pig ileum smooth muscle membranes with a selective, iodinatable, bradykinin analogue.
C Liebmann, R Bossé and E Escher

Molecular Pharmacology November 1994, 46 (5) 949-956;
You have access
Molecular pharmacology of gamma-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different alpha, beta, and gamma receptor subunit combinations.
B Ebert, K A Wafford, P J Whiting, P Krogsgaard-Larsen and J A Kemp

Molecular Pharmacology November 1994, 46 (5) 957-963;
You have access
Amino- and carboxyl-terminal domains specify the identity of the delta subunit in assembly of the mouse muscle nicotinic acetylcholine receptor.
X M Yu and Z W Hall

Molecular Pharmacology November 1994, 46 (5) 964-969;
You have access
Block of the inactivating potassium channel by clofilium and hydroxylamine depends on the sequence of the pore region.
A J Yool

Molecular Pharmacology November 1994, 46 (5) 970-976;
You have access
Correlation of neuroactive steroid modulation of [35S]t-butylbicyclophosphorothionate and [3H]flunitrazepam binding and gamma-aminobutyric acidA receptor function.
J E Hawkinson, C L Kimbrough, D Belelli, J J Lambert, R H Purdy and N C Lan

Molecular Pharmacology November 1994, 46 (5) 977-985;
You have access
Glutamate uptake is inhibited by arachidonic acid and oxygen radicals via two distinct and additive mechanisms.
A Volterra, D Trotti and G Racagni

Molecular Pharmacology November 1994, 46 (5) 986-992;
You have access
Functional heterogeneity of nicotinic receptors in the avian lateral spiriform nucleus detected with trimethaphan.
W R Weaver, K M Wolf and V A Chiappinelli

Molecular Pharmacology November 1994, 46 (5) 993-1001;
You have access
Enhancement by 2'-deoxycoformycin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of 2',3'-dideoxyadenosine and 2'-beta-fluoro-2',3'-dideoxyadenosine.
G S Ahluwalia, D A Cooney, T Shirasaka, H Mitsuya, J S Driscoll and D G Johns

Molecular Pharmacology November 1994, 46 (5) 1002-1008;
You have access
New aspects of the kinetics of inhibition by lincomycin of peptide bond formation.
S Kallia-Raftopoulos, D L Kalpaxis and C Coutsogeorgopoulos

Molecular Pharmacology November 1994, 46 (5) 1009-1014;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals